Work

Advancing the beneficial use of machine learning in health care and medicine: Toward a community understanding

Year: 2018
Type: editorial
Abstract: Due to the abundance of health data and growing computational power, machine learning (ML) is engaging health researchers in a process of discovery around developing data-driven algorithms to make clinically reliable predictions.ML has the potential to provide effective tools to improve outcomes and reduce costs in health care, and the clinical community should partake in developing and evaluating these discoveries.However, if misguided applications are to be avoided, methodological savvy will be needed to develop, interpret and implement ML in medicine [1,2].In preparing PLOS Medicine's Special Issue (SI) on Machine Learning in Health and Biomedicine, Guest Editors Atul Butte, Suchi Saria, and Aziz Sheikh, and the PLOS Medicine Editors, have identified two principles in the design and reporting of ML studies that we believe should guide researchers in advancing the beneficial use of ML in healthcare and medicine.These principles, which also inform PLOS Medicine's editorial priorities for manuscript submissions in this field, require first, that models derived through ML are demonstrably fit for their stated clinical purpose, and second, that researchers undertake and report appropriate efforts to validate these models in external datasets. Fit-for-purpose performanceAn ML model need not be ready for off-the-shelf, practice-changing implementation to make a valuable contribution, but must achieve a clear purpose.The current SI includes reports on ML approaches that have undergone retrospective validation and are now ready for prospective testing, ML at early stages of validation, and head-to-head comparisons between standard epidemiological and ML approaches that suggest future directions without themselves establishing clinical utility.The articles vary widely in the intended application or "use cases" for their models.In a study from Soo-Jin Kang and colleagues, ML deploying imaging data from intravascular coronary angiography was used to diagnose coronary ischemia without a more invasive measurement-fractional flow reserve-that is currently the diagnostic standard [3].The authors were not trying to challenge the standard of care, but to improve diagnosis when resource constraints or clinical indications make fractional flow reserve impractical or unsuitable.For applications intended to provide pragmatic options for nonideal circumstances, model performance can be benchmarked against current practice rather than recommended practice, as long as the limitations of the advance are clear to readers.Early research planning should consider clinically acceptable performance characteristics for the targeted application, and a clear description of its intended use-and inappropriate
Authors: Linda Nevin, on behalf of the PLOS Medicine Editors
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $6,460
OpenAlex ID: W2902239438
Cites: 10
Cited by: 63
Related to: 10